Teva Presents Data Comparing Early Treatment with COPAXONE® 40 mg/mL to Delayed Start Treatment at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.
Business Wire, 23 Apr 2015
Accessed on 28 Apr 2015 from http://www.businesswire.com/news/home/20150423005324/en/Teva-Presents-Data-Comparing-Early-Treatment-COPAXONE®#.VT-C_ijOZiY.
